Stake Announced
CPP Investments stake in CVC and GBL-led Recordati acquisition consortium
Announced May 2026
Advisers
CVC and GBL-led Recordati acquisition consortium
Target
Not disclosed
CPP Investments
Acquirer
- Legal adviser
- Target
- CVC and GBL-led Recordati acquisition consortium
- Acquirer
- CPP Investments
- Buyer based in
- Canada
- Structure
- Minority stake
- Sector
- Pharma
Similar deals
- Fresenius acquisition of mAbxience Oct 2026 · US$1.9bn · Biotech
- Gilead acquisition of HCXT-2001 (investigational oral IL-23R inhibitor) Oct 2026 · Pharma
- US WorldMeds acquisition of Orbus Therapeutics Oct 2026 · Pharma
- DRI Healthcare Trust acquisition of Royalty participation rights in U.S. net sales of tavapadon Sep 2026 · US$316m · Specialty finance and leasing
- Grünenthal acquisition of Stivarga (regorafenib) Sep 2026 · US$433m · Pharma
